European Investor
31 Mar 2026, 22:31
Bristol Myers Squibb announced the expansion of its “Standing in the Gaap” program to improve equitable care for patients with multiple myeloma, marking the initiative’s 10th anniversary.
As part of the expansion, the company is launching one of the largest U.S. surveys on multiple myeloma, engaging over 1,000 patients, caregivers, and healthcare providers to better understand persistent gaps in care. Developed with input from major patient advocacy groups, the survey aims to capture real-world experiences and identify barriers faced by underserved communities.
Originally launched in 2016 to address disparities affecting African American patients, the program has reached thousands through educational initiatives and built a large digital community. Bristol Myers Squibb said insights from the new survey will guide future programs, partnerships, and strategies to enhance access, education, and support across the multiple myeloma care ecosystem.
Business Wire
As part of the expansion, the company is launching one of the largest U.S. surveys on multiple myeloma, engaging over 1,000 patients, caregivers, and healthcare providers to better understand persistent gaps in care. Developed with input from major patient advocacy groups, the survey aims to capture real-world experiences and identify barriers faced by underserved communities.
Originally launched in 2016 to address disparities affecting African American patients, the program has reached thousands through educational initiatives and built a large digital community. Bristol Myers Squibb said insights from the new survey will guide future programs, partnerships, and strategies to enhance access, education, and support across the multiple myeloma care ecosystem.
Business Wire